Duke Researchers Cut Nerve Pain by 50% With Mitochondria Transfer
Updated
Updated · ScienceDaily · May 25
Duke Researchers Cut Nerve Pain by 50% With Mitochondria Transfer
6 articles · Updated · ScienceDaily · May 25
Mouse tests showed pain-related behaviors fell by as much as 50% when Duke researchers boosted the transfer of healthy mitochondria into damaged sensory neurons.
Nature-published experiments in human tissue and mouse models linked chronic pain to failing nerve-cell energy supply, and direct mitochondrial injections eased diabetic neuropathy and chemotherapy-related nerve damage for up to 48 hours.
Satellite glial cells appeared to pass mitochondria into neurons through tunneling nanotubes, a support pathway the team said breaks down as nerve fibers deteriorate and pain, tingling and numbness emerge.
The benefit depended on mitochondrial quality—healthy donor mitochondria reduced pain, while mitochondria from people with diabetes did not—and the team identified MYO10 as a key protein enabling the nanotube transfer.
Researchers said higher-resolution imaging and further studies are still needed, but the work points to a way to treat chronic pain at its source rather than only blocking symptoms.
Could mitochondrial transplants be the key to treating diseases far beyond chronic pain?
Will 'recharging' nerves make emerging non-opioid drugs and therapies obsolete?
How long does a mitochondrial 'recharge' last before a damaged nerve fails again?
Duke’s Mitochondrial Transfer Discovery: A Paradigm Shift in Treating Chronic Nerve Pain at the Cellular Level
Overview
Duke University researchers have made a major breakthrough by discovering that transferring healthy mitochondria into damaged nerve cells can significantly reduce chronic nerve pain. This novel approach goes beyond just managing symptoms, aiming instead to fix the underlying cellular dysfunction that causes the pain. By replenishing the energy-producing components in nerve cells, mitochondrial transfer offers a promising new direction for treatment. Early studies highlight its potential, marking an important step forward in understanding and addressing chronic nerve pain at its root cause.